- Home
- CCK vs PEN Comparison
CCK vs PEN Comparison
Compare CCK & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCK
- PEN
- Stock Information
- Founded
- CCK 1906
- PEN 2004
- Country
- CCK United States
- PEN United States
- Employees
- CCK N/A
- PEN N/A
- Industry
- CCK Containers/Packaging
- PEN Medical/Dental Instruments
- Sector
- CCK Industrials
- PEN Health Care
- Exchange
- CCK Nasdaq
- PEN Nasdaq
- Market Cap
- CCK 10.4B
- PEN 11.1B
- IPO Year
- CCK N/A
- PEN 2015
- Fundamental
- Price
- CCK $89.24
- PEN $267.21
- Analyst Decision
- CCK Strong Buy
- PEN Strong Buy
- Analyst Count
- CCK 13
- PEN 16
- Target Price
- CCK $104.85
- PEN $291.60
- AVG Volume (30 Days)
- CCK 1.4M
- PEN 412.9K
- Earning Date
- CCK 04-28-2025
- PEN 05-06-2025
- Dividend Yield
- CCK 1.17%
- PEN N/A
- EPS Growth
- CCK N/A
- PEN N/A
- EPS
- CCK 3.55
- PEN 0.36
- Revenue
- CCK $11,801,000,000.00
- PEN $1,194,615,000.00
- Revenue This Year
- CCK $2.44
- PEN $14.26
- Revenue Next Year
- CCK $2.49
- PEN $14.29
- P/E Ratio
- CCK $24.85
- PEN $742.64
- Revenue Growth
- CCK N/A
- PEN 12.86
- 52 Week Low
- CCK $70.84
- PEN $148.00
- 52 Week High
- CCK $98.46
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- CCK 51.68
- PEN 43.99
- Support Level
- CCK $86.63
- PEN $273.00
- Resistance Level
- CCK $90.19
- PEN $288.57
- Average True Range (ATR)
- CCK 1.90
- PEN 8.17
- MACD
- CCK -0.12
- PEN -1.26
- Stochastic Oscillator
- CCK 58.13
- PEN 33.31
About CCK Crown Holdings Inc.
Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.